aluates Reports

$ 0.0

Automative

Zoster Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-30M11984

Global Zoster Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Zoster Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-30M11984

Report

September 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Merck

Sanofi Pasteur

SK Chemicals

Green Cross Corp

Zoster Vaccine - Market Size

The global market for Zoster Vaccine was estimated to be worth US$ 3152 million in 2023 and is forecast to a readjusted size of US$ 6142 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030

Zoster Vaccine - Market

Zoster vaccines are two vaccines that have been shown to reduce the rates of herpes zoster (also known as shingles).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Zoster Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Zoster Vaccine by region & country, by Type, and by Application.

The Zoster Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zoster Vaccine.

Market Segmentation

Scope of Zoster Vaccine - Market Report

Report Metric	Details
Report Name	Zoster Vaccine - Market
Forecasted market size in 2030	US$ 6142 million
CAGR	10.0%
Forecasted years	2024 - 2030
Segment by Type:	Live Attenuated Vaccine Recombinant
Segment by Application	Government Institution Private Sector Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Merck, Sanofi Pasteur, SK chemicals, Green Cross Corp
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Zoster Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Zoster Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Zoster Vaccine - Market size in 2030?

Ans: The Zoster Vaccine - Market size in 2030 will be US$ 6142 million.

Who are the main players in the Zoster Vaccine - Market report?

Ans: The main players in the Zoster Vaccine - Market are GSK, Merck, Sanofi Pasteur, SK chemicals, Green Cross Corp

What are the Application segmentation covered in the Zoster Vaccine - Market report?

Ans: The Applications covered in the Zoster Vaccine - Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Zoster Vaccine - Market report?

Ans: The Types covered in the Zoster Vaccine - Market report are Live Attenuated Vaccine, Recombinant

Recommended Reports

Vaccine Markets

Vaccine Packaging

Vaccine Adjuvants

1 Market Overview

1.1 Zoster Vaccine Product Introduction

1.2 Global Zoster Vaccine Market Size Forecast

1.2.1 Global Zoster Vaccine Sales Value (2019-2030)

1.2.2 Global Zoster Vaccine Sales Volume (2019-2030)

1.2.3 Global Zoster Vaccine Sales Price (2019-2030)

1.3 Zoster Vaccine Market Trends & Drivers

1.3.1 Zoster Vaccine Industry Trends

1.3.2 Zoster Vaccine Market Drivers & Opportunity

1.3.3 Zoster Vaccine Market Challenges

1.3.4 Zoster Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Zoster Vaccine Players Revenue Ranking (2023)

2.2 Global Zoster Vaccine Revenue by Company (2019-2024)

2.3 Global Zoster Vaccine Players Sales Volume Ranking (2023)

2.4 Global Zoster Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Zoster Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Zoster Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Zoster Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Zoster Vaccine

2.9 Zoster Vaccine Market Competitive Analysis

2.9.1 Zoster Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Zoster Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zoster Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Live Attenuated Vaccine

3.1.2 Recombinant

3.2 Global Zoster Vaccine Sales Value by Type

3.2.1 Global Zoster Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Zoster Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Zoster Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Zoster Vaccine Sales Volume by Type

3.3.1 Global Zoster Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Zoster Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Zoster Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Zoster Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Government Institution

4.1.2 Private Sector

4.1.3 Other

4.2 Global Zoster Vaccine Sales Value by Application

4.2.1 Global Zoster Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Zoster Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Zoster Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Zoster Vaccine Sales Volume by Application

4.3.1 Global Zoster Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Zoster Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Zoster Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Zoster Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Zoster Vaccine Sales Value by Region

5.1.1 Global Zoster Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Zoster Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Zoster Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Zoster Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Zoster Vaccine Sales Volume by Region

5.2.1 Global Zoster Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Zoster Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Zoster Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Zoster Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Zoster Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Zoster Vaccine Sales Value, 2019-2030

5.4.2 North America Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Zoster Vaccine Sales Value, 2019-2030

5.5.2 Europe Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Zoster Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Zoster Vaccine Sales Value, 2019-2030

5.7.2 South America Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Zoster Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Zoster Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Zoster Vaccine Sales Value

6.2.1 Key Countries/Regions Zoster Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Zoster Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Zoster Vaccine Sales Value, 2019-2030

6.3.2 United States Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Zoster Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Zoster Vaccine Sales Value, 2019-2030

6.4.2 Europe Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Zoster Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Zoster Vaccine Sales Value, 2019-2030

6.5.2 China Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Zoster Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Zoster Vaccine Sales Value, 2019-2030

6.6.2 Japan Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Zoster Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Zoster Vaccine Sales Value, 2019-2030

6.7.2 South Korea Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Zoster Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Zoster Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Zoster Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Zoster Vaccine Sales Value, 2019-2030

6.9.2 India Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Zoster Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GSK

7.1.1 GSK Company Information

7.1.2 GSK Introduction and Business Overview

7.1.3 GSK Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GSK Zoster Vaccine Product Offerings

7.1.5 GSK Recent Development

7.2 Merck

7.2.1 Merck Company Information

7.2.2 Merck Introduction and Business Overview

7.2.3 Merck Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merck Zoster Vaccine Product Offerings

7.2.5 Merck Recent Development

7.3 Sanofi Pasteur

7.3.1 Sanofi Pasteur Company Information

7.3.2 Sanofi Pasteur Introduction and Business Overview

7.3.3 Sanofi Pasteur Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Pasteur Zoster Vaccine Product Offerings

7.3.5 Sanofi Pasteur Recent Development

7.4 SK chemicals

7.4.1 SK chemicals Company Information

7.4.2 SK chemicals Introduction and Business Overview

7.4.3 SK chemicals Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 SK chemicals Zoster Vaccine Product Offerings

7.4.5 SK chemicals Recent Development

7.5 Green Cross Corp

7.5.1 Green Cross Corp Company Information

7.5.2 Green Cross Corp Introduction and Business Overview

7.5.3 Green Cross Corp Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Green Cross Corp Zoster Vaccine Product Offerings

7.5.5 Green Cross Corp Recent Development

8 Industry Chain Analysis

8.1 Zoster Vaccine Industrial Chain

8.2 Zoster Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Zoster Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Zoster Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GSK

Merck

Sanofi Pasteur

SK Chemicals

Green Cross Corp

List of Tables

Table 1. Zoster Vaccine Market Trends

Table 2. Zoster Vaccine Market Drivers & Opportunity

Table 3. Zoster Vaccine Market Challenges

Table 4. Zoster Vaccine Market Restraints

Table 5. Global Zoster Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Zoster Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Zoster Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Zoster Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Zoster Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Zoster Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Zoster Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Zoster Vaccine

Table 13. Global Zoster Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zoster Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Zoster Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Zoster Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Zoster Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Zoster Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Zoster Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Zoster Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Zoster Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Zoster Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Zoster Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Zoster Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Zoster Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Zoster Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Zoster Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Zoster Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Zoster Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Zoster Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Zoster Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Zoster Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Zoster Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Zoster Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Zoster Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Zoster Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Zoster Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Zoster Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Zoster Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Zoster Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Zoster Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Zoster Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Zoster Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Zoster Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Zoster Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Zoster Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Zoster Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Zoster Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Zoster Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Zoster Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Zoster Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Zoster Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Zoster Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Zoster Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Zoster Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. GSK Company Information

Table 58. GSK Introduction and Business Overview

Table 59. GSK Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. GSK Zoster Vaccine Product Offerings

Table 61. GSK Recent Development

Table 62. Merck Company Information

Table 63. Merck Introduction and Business Overview

Table 64. Merck Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Merck Zoster Vaccine Product Offerings

Table 66. Merck Recent Development

Table 67. Sanofi Pasteur Company Information

Table 68. Sanofi Pasteur Introduction and Business Overview

Table 69. Sanofi Pasteur Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Pasteur Zoster Vaccine Product Offerings

Table 71. Sanofi Pasteur Recent Development

Table 72. SK chemicals Company Information

Table 73. SK chemicals Introduction and Business Overview

Table 74. SK chemicals Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. SK chemicals Zoster Vaccine Product Offerings

Table 76. SK chemicals Recent Development

Table 77. Green Cross Corp Company Information

Table 78. Green Cross Corp Introduction and Business Overview

Table 79. Green Cross Corp Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Green Cross Corp Zoster Vaccine Product Offerings

Table 81. Green Cross Corp Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Zoster Vaccine Downstream Customers

Table 85. Zoster Vaccine Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Zoster Vaccine Product Picture

Figure 2. Global Zoster Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Zoster Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Zoster Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Zoster Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Zoster Vaccine Report Years Considered

Figure 7. Global Zoster Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Zoster Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Zoster Vaccine Revenue in 2023

Figure 10. Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Live Attenuated Vaccine Picture

Figure 12. Recombinant Picture

Figure 13. Global Zoster Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Zoster Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Zoster Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Zoster Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Zoster Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Government Institution

Figure 19. Product Picture of Private Sector

Figure 20. Product Picture of Other

Figure 21. Global Zoster Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Zoster Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Zoster Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Zoster Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Zoster Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Zoster Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Zoster Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Zoster Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Zoster Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Zoster Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Zoster Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Zoster Vaccine Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Zoster Vaccine Sales Volume (%), (2019-2030)

Figure 38. United States Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 44. China Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 46. China Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 56. India Zoster Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Zoster Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 58. India Zoster Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 59. Zoster Vaccine Industrial Chain

Figure 60. Zoster Vaccine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Zoster Vaccine Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Varicella Live Vaccine Market Insights Forecast to 2030

Global Recombinant Zoster Vaccine Market Research Report 2025

Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030

Global Herpes Zoste Drug Market Research Report 2025

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Zoster Treatment Market Insights Forecast to 2030

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Varicella Vaccine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Measles Mumps and Rubella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chickenpox Varicella Vaccine Market

Global Avian Pox Vaccine Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions